Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Heritage Group

Investor type Venture Capital
Founders David McClellan Rock Morphis

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 50
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 34
Rounds per year 1.39
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.26
Exits 13
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Software
  • Information Technology
  • Hospital
  • Enterprise Software

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Heritage Group:
Typical Co-investors
Heritage Group is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Heritage Group:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AMP Ventures Houston, Texas, United States
Bank of Fukuoka Fukuoka, Fukuoka Prefecture, Japan
Berti Green Accelerator England, London, United Kingdom
Bochuang Zhilian Beijing, China, Haidian
Clover Health Nashville, Tennessee, United States
Copper New York, New York, United States
Financial Services Capital Partners England, London, United Kingdom
Hambro Perks Ltd. England, London, United Kingdom
Impact46 Ar Riyad, Riyadh, Saudi Arabia
Knight Enterprise Fund Florida, Miami, United States
Lothian Partners England, London, United Kingdom
Manifest Investment Partners Belvedere Tiburon, California, United States
Mitsui Sumitomo Insurance Company Chiyoda, Japan
New Mexico State Investment Council New Mexico, Santa Fe, United States
Orpi France, Ile-de-France, Paris
Segue Group Hokkaido Prefecture, Japan, Sapporo
Slater Technology Fund Providence, Rhode Island, United States
Tipping Point Partners New York, New York, United States
Unilumin Group China, Guangdong, Shenzhen
Valor Ventures Atlanta, Georgia, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ZwitterCo

Environmental Consulting
Health Care
Renewable Energy
$33M15 Sep 2022 Cambridge, Massachusetts, United States

Upward Health

13 Sep 2022 Providence, Rhode Island, United States

Transfoam

Biotechnology
$150K05 Aug 2022 Charlottesville, Virginia, United States

TwelveStone Health Partners

Health Care
Hospital
Medical
Pharmaceutical
12 Jul 2022 Murfreesboro, Tennessee, United States

Simplifyber

Advanced Materials
Chemical Engineering
CleanTech
Fashion
Manufacturing
Sustainability
$3M06 Jul 2022 -

CyCognito

Cloud Security
Cyber Security
Information Technology
Network Security
$100M01 Dec 2021 Palo Alto, California, United States

Daily.co

Apps
Audio
Communication Hardware
Developer Platform
Real Time
Software
Video
Video Chat
Video Conferencing
Video Streaming
$40M10 Nov 2021 Mountain View, California, United States

Biond Biologics

Biotechnology
Health Care
Pharmaceutical
$15M03 Nov 2021 Misgav Regional Council, North District, Israel

SimBioSys

Biotechnology
Life Science
Pharmaceutical
$15M26 Oct 2021 Champaign, Illinois, United States
News
SimBioSys Raises $15 Million Series A to Develop the Future of Precision Cancer Care

– SimBioSys announced it raised $15m in Series A funding to accelerate the development and commercialization of its TumorScope software platform.
– The company’s novel, simulation-based, precision medicine platform enables individualized treatment planning for cancer patients.
– This Series A was co-led by Genoa Ventures and Northpond Ventures, with participation from AV8 Ventures, Heritage Medical Group, and Mayo Clinic.
– Existing investors and founders also participated in this financing round, bringing the company’s total capital raised to $21m.
– In the first half of 2021, SimBioSys tripled its headcount, bringing in expert clinicians, scientists, and executives from the life sciences industry.

Upward Health Announces Significant Growth Equity Investment Led by Heritage Group

– Upward Health raised a significant equity financing led by Heritage Group, with participation from existing investors including Noro-Moseley Partners, the Blue Venture Fund and Windham Ventures.
– The company partners with health plans, taking on risk and guaranteeing outcomes in both cost and quality across their most complex and high-cost populations.
– The company pairs these members with care specialists who form trusted relationships and coordinate all aspects of the members’ care.
– Upward Health enables Facilitated Virtual Care™ visits with Upward Health providers and works to support and strengthen any existing member relationships with primary care physicians.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Heritage Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: